China Resources Pharmaceutical Group Limited (HKG:3320)
4.450
+0.090 (2.06%)
Sep 30, 2026, 4:08 PM HKT
HKG:3320 Market Cap
HKG:3320 has a market cap or net worth of 27.96 billion as of October 1, 2026. Its market cap has decreased by -6.51% in one year.
Market Cap
27.96B
Enterprise Value
159.27B
Revenue
314.21B
Ranking
n/a
PE Ratio
5.83
Stock Price
4.45
ChartMarket Cap Chart
Since October 28, 2016, HKG:3320's market cap has decreased from 55.61B to 27.96B, a decrease of -49.73%. That is a compound annual growth rate of -6.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 27.96B | - |
| Dec 31, 2025 | 27.96B | -21.93% |
| Dec 31, 2024 | 35.81B | 11.11% |
| Dec 29, 2023 | 32.23B | -18.83% |
| Dec 30, 2022 | 39.71B | 78.03% |
| Dec 31, 2021 | 22.30B | -10.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simcere Pharmaceutical Group | 28.87B |
| China Medical System Holdings | 25.50B |
| Sunshine Lake Pharma | 23.45B |
| Grand Pharmaceutical Group | 16.95B |
| CanSino Biologics | 15.83B |
| The United Laboratories International Holdings | 15.32B |
| Fujian Haixi Pharmaceuticals | 13.03B |
| Consun Pharmaceutical Group | 12.21B |